Related Experiment Video

Updated: Oct 9, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis

K Bogunia-Kubik1, J Tomeczko, K Suchnicki

  • 1L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland.

Tissue Antigens
|February 13, 2001
PubMed

Insights

Human leukocyte antigen (HLA) DRB1 and DRB3 gene specificities influence sarcoidosis disease course. Specific HLA types, like DRB1*03, are linked to Löfgren's syndrome, while others, like DRB1*11/12, are associated with less severe disease.

Area of Science:

  • Immunogenetics
  • Rheumatology
  • Pulmonary Medicine

Background:

  • Sarcoidosis is an inflammatory disease characterized by granuloma formation.
  • Human leukocyte antigen (HLA) genes, particularly HLA-DRB1 and HLA-DRB3, are implicated in sarcoidosis susceptibility and clinical presentation.
  • Specific HLA alleles may influence the distinct clinical phenotypes observed in sarcoidosis patients.

Purpose of the Study:

  • To investigate the association between HLA-DRB1 and HLA-DRB3 specificities and the clinical course of sarcoidosis.
  • To determine if specific HLA alleles correlate with the presence of Löfgren's syndrome or stage I sarcoidosis.
  • To explore combined associations of HLA-DRB1 and HLA-DRB3 alleles in sarcoidosis variants.

Main Methods:

  • Genotyping of HLA-DRB1 and HLA-DRB3 alleles in a cohort of sarcoidosis patients.
  • Statistical analysis to correlate specific HLA alleles with clinical phenotypes, including Löfgren's syndrome and disease staging.
  • Examination of combined associations between HLA-DRB1 and HLA-DRB3 alleles.

Main Results:

  • The presence of HLA-DRB1*03 was positively associated with Löfgren's syndrome.
  • The absence of HLA-DRB1*11 and/or HLA-DRB1*12 was negatively associated with stage I sarcoidosis.
  • HLA-DRB1*03 and HLA-DRB3*0101 showed a combined association with Löfgren's syndrome.
  • HLA-DRB1*11/12 alleles were associated with HLA-DRB3*0201/2, similar to normal controls.

Conclusions:

  • Specific HLA-DRB1 alleles, particularly DRB1*03, are significant predictors of Löfgren's syndrome in sarcoidosis.
  • The absence of certain HLA-DRB1 alleles (DRB1*11/12) is linked to a less advanced stage of sarcoidosis.
  • These findings highlight the role of immunogenetics in shaping sarcoidosis clinical trajectories.

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...